Patrick Baeuerle

2022

In 2022, Patrick Baeuerle earned a total compensation of $2M as Chief Scientific Officer at Cullinan Therapeutics, a 58% decrease compared to previous year.

Compensation breakdown

Bonus$266,234
Option Awards$686,250
Salary$463,500
Stock Awards$510,000
Other$34,000
Total$1,959,984

Baeuerle received $686.3K in option awards, accounting for 35% of the total pay in 2022.

Baeuerle also received $266.2K in bonus, $463.5K in salary, $510K in stock awards and $34K in other compensation.

Rankings

In 2022, Patrick Baeuerle's compensation ranked 1,779th out of 5,672 executives tracked by ExecPay. In other words, Baeuerle earned more than 68.6% of executives.

ClassificationRankingPercentile
All
1,779
out of 5,672
69th
Division
Manufacturing
933
out of 3,081
70th
Major group
Chemicals And Allied Products
375
out of 1,396
73rd
Industry group
Drugs
343
out of 1,297
74th
Industry
Biological Products, Except Diagnostic Substances
86
out of 295
71st
Source: SEC filing on April 21, 2023.

Baeuerle's colleagues

We found two more compensation records of executives who worked with Patrick Baeuerle at Cullinan Therapeutics in 2022.

2022

Nadim Ahmed

Cullinan Therapeutics

Chief Executive Officer

2022

Jeffrey Trigilio

Cullinan Therapeutics

Chief Financial Officer

News

You may also like